IKS Health, a global leader in care enablement solutions, has announced the strategic acquihire of ThinkDTM, an AI-native product, strategy, and digital services company. This move includes the addition of ThinkDTM Founder Tij Bedi, who will take on the role of Executive Vice President and General Manager, Patient Access and Innovation. Bedi, along with his team of AI technology experts, will integrate into IKS Health to bolster its patient access solutions.
Bedi expressed enthusiasm about joining IKS Health, citing the opportunity to intelligently implement AI to improve patient experiences. As an engineer and problem solver, Bedi is eager to contribute to the health-tech organisation during a period of significant industry change.
The integration of Bedi and his team is expected to drive the strategic expansion and transformation of IKS Health’s patient access solutions, which include patient scheduling, registration, demographic capture, insurance eligibility verification, and prior authorisations. The focus will be on building and scaling differentiated patient access solutions, enhancing platform capabilities, and fostering innovation that improves outcomes for healthcare providers and patients. Additionally, Bedi will play a key role in forming strategic partnerships that leverage technology to create unique market opportunities.
Sachin K. Gupta, Founder and Global CEO of IKS Health, highlighted the importance of Bedi and his team in expanding the company’s AI capabilities, particularly in the realm of agentic AI. Gupta expressed excitement about Bedi’s leadership in addressing complex healthcare challenges through AI and human-in-the-loop expertise.
IKS Health, founded in 2006, is recognised for reducing administrative, clinical, and operational burdens in healthcare. The company integrates agentic AI workflows with human expertise to enhance operations, outcomes, and financial sustainability across the care journey. It has been acknowledged by Black Book, KLAS, and Google Cloud for its AI-driven services and partnerships with major health systems in the United States.
Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).